{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.332",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "B.well Connected Health Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-06-16"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-06-16"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1235.332"
    }
  ],
  "version" : "20230616",
  "name" : "HighRiskHPVTest_HD_Grouping",
  "title" : "High Risk HPV Test_HD_Grouping",
  "status" : "active",
  "date" : "2023-06-16T01:00:56-04:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:80ae7a64-165a-4fae-aced-c60f8a2aa4b7",
    "timestamp" : "2024-06-14T14:44:58-04:00",
    "total" : 24,
    "contains" : [
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "21440-3",
        "display" : "Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "30167-1",
        "display" : "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "35904009",
        "display" : "Human papillomavirus deoxyribonucleic acid detection (procedure)"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "38372-9",
        "display" : "Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "441667007",
        "display" : "Abnormal cervical Papanicolaou smear with human papillomavirus deoxyribonucleic acid detected (finding)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "448651000124104",
        "display" : "Microscopic examination of cervical Papanicolaou smear and Human papillomavirus deoxyribonucleic acid detection cotesting (procedure)"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "59263-4",
        "display" : "Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "59264-2",
        "display" : "Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "59420-0",
        "display" : "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "69002-4",
        "display" : "Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "71431-1",
        "display" : "Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "718591004",
        "display" : "High risk human papillomavirus detected by cytology (finding)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "720005005",
        "display" : "Human papillomavirus deoxyribonucleic acid detected, high risk on cervical specimen (finding)"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "75694-0",
        "display" : "Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "77379-6",
        "display" : "Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "77399-4",
        "display" : "Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "77400-0",
        "display" : "Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "82354-2",
        "display" : "Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "82456-5",
        "display" : "Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "82675-0",
        "display" : "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2024",
        "code" : "87624",
        "display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2024",
        "code" : "87625",
        "display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.77",
        "code" : "95539-3",
        "display" : "Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G0476",
        "display" : "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
      }
    ]
  }
}
